Follow
Stefan Leucht
Stefan Leucht
Prof. Dr. med., Klinik für Psychiatrie und Psychotherapie der TU-München
Verified email at lrz.tum.de
Title
Cited by
Cited by
Year
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
S Leucht, A Cipriani, L Spineli, D Mavridis, D Örey, F Richter, M Samara, ...
The Lancet 382 (9896), 951-962, 2013
25372013
Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
S Leucht, C Corves, D Arbter, RR Engel, C Li, JM Davis
The Lancet 373 (9657), 31-41, 2009
23432009
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
M De Hert, CU Correll, J Bobes, M Cetkovich-Bakmas, DAN Cohen, I Asai, ...
World psychiatry 10 (1), 52, 2011
22802011
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis
A Cipriani, TA Furukawa, G Salanti, A Chaimani, LZ Atkinson, Y Ogawa, ...
Focus 16 (4), 420-429, 2018
20932018
What does the PANSS mean?
S Leucht, JM Kane, W Kissling, J Hamann, E Etschel, RR Engel
Schizophrenia research 79 (2-3), 231-238, 2005
11132005
Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A …
S Leucht, G Pitschel-Walz, D Abraham, W Kissling
Schizophrenia research 35 (1), 51-68, 1999
11091999
The effect of family interventions on relapse and rehospitalization in schizophrenia—a meta-analysis
G Pitschel-Walz, S Leucht, J Bäuml, W Kissling, RR Engel
Schizophrenia bulletin 27 (1), 73-92, 2001
9702001
Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis
S Leucht, M Tardy, K Komossa, S Heres, W Kissling, G Salanti, JM Davis
The Lancet 379 (9831), 2063-2071, 2012
9462012
Opioid antagonists for alcohol dependence
S Roesner, A Hackl‐Herrwerth, S Leucht, S Vecchi, M Srisurapanont, ...
Cochrane database of systematic reviews, 2010
9302010
Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level
M De Hert, DAN Cohen, J Bobes, M Cetkovich-Bakmas, S Leucht, ...
World psychiatry 10 (2), 138, 2011
9162011
Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies
CU Correll, S Leucht, JM Kane
American Journal of psychiatry 161 (3), 414-425, 2004
8692004
Physical illness and schizophrenia: a review of the literature
S Leucht, T Burkard, J Henderson, M Maj, N Sartorius
Acta Psychiatrica Scandinavica 116 (5), 317-333, 2007
8512007
Clinical implications of brief psychiatric rating scale scores
S Leucht, JM Kane, W Kissling, J Hamann, EVA Etschel, R Engel
The British Journal of Psychiatry 187 (4), 366-371, 2005
8152005
Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis
C Rummel-Kluge, K Komossa, S Schwarz, H Hunger, F Schmid, ...
Schizophrenia research 123 (2-3), 225-233, 2010
7812010
New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis
S Leucht, K Wahlbeck, J Hamann, W Kissling
The Lancet 361 (9369), 1581-1589, 2003
7462003
Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
M Huhn, A Nikolakopoulou, J Schneider-Thoma, M Krause, M Samara, ...
The Lancet 394 (10202), 939-951, 2019
7392019
Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials
S Leucht, TRE Barnes, W Kissling, RR Engel, C Correll, JM Kane
American Journal of Psychiatry 160 (7), 1209-1222, 2003
6772003
A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia
S Leucht, K Komossa, C Rummel-Kluge, C Corves, H Hunger, F Schmid, ...
American Journal of Psychiatry 166 (2), 152-163, 2009
6422009
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis
A Cipriani, X Zhou, C Del Giovane, SE Hetrick, B Qin, C Whittington, ...
The Lancet 388 (10047), 881-890, 2016
6032016
Clozapine versus other atypical antipsychotics for schizophrenia
CA Lobos, K Komossa, C Rummel‐Kluge, H Hunger, F Schmid, ...
Cochrane Database of Systematic Reviews, 2010
591*2010
The system can't perform the operation now. Try again later.
Articles 1–20